What is Dow Development Laboratories?
Dow Development Laboratories operates as a contract development and manufacturing organization (CDMO) with a specialized focus on pharmaceutical drug product development and testing services. Catering to pharmaceutical and biotech companies, their comprehensive service portfolio includes formulation development, analytical method validation, and clinical packaging. The company's expertise, particularly in topical products, is instrumental in accelerating clients' drug products through development and toward regulatory approval. Based in Northern California, Dow Development Laboratories adheres to FDA-registered and cGMP compliant standards, ensuring high-quality service delivery and maintaining proactive client communication.
How much funding has Dow Development Laboratories raised?
Dow Development Laboratories has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
What's next for Dow Development Laboratories?
The substantial backing, indicated by the $350K in total funding and the recent $350K strategic investment, positions Dow Development Laboratories for significant expansion. This capital infusion is expected to fuel advancements in their service offerings, potentially broadening their scope in formulation development and analytical testing. The company's late-stage funding context suggests a focus on scaling operations, enhancing manufacturing capacity, and potentially exploring new therapeutic areas or product types. Strategic partnerships and further R&D initiatives are likely next steps as they leverage this financing to solidify their market leadership and support a growing client base in the pharmaceutical and biotech industries.
See full Dow Development Laboratories company page
